Market evolution: Medical furniture (CN 940290) — 2015–2025

Introduction

This report analyses the evolution of the European Union's external trade in medical, dental, surgical, or veterinary furniture (excluding certain specific items), classified under Combined Nomenclature code 940290, for the period from 2015 to 2025. The EU has consistently maintained a positive trade balance in this sector, though the dynamics of its imports and exports have undergone notable shifts. By examining trends in value, volume, pricing, key partners, and strategic positioning, this report identifies the EU's strengthening role as a major global exporter while highlighting the simultaneous and rapid growth of its import needs, primarily from Asia.

I. The EU's Enduring Export Dominance in a Growing Global Market

The European Union has solidified its position as the world's leading exporter of medical furniture throughout the 2015–2025 period. This dominance is underpinned by high-value, competitive production concentrated in a few key member states.

Export Value Growth Outpaces Quantity, Signifying a Move Upmarket

Over the period, EU exports grew substantially in value (+36.1%), reaching €878 million by 2025. In contrast, the quantity exported remained relatively stable (-0.6%). This divergence led to a significant increase in the average export price, which rose by 36.9% to over €25,500 per tonne. This dynamic suggests a successful shift towards higher-value, technologically advanced, or specialized medical furniture products.

A Concentrated Core of Exporting Nations Drives Performance

The EU's export strength is concentrated in a handful of member states, led by Germany, which consistently accounted for the largest share of exports. Other significant contributors include Czechia, Poland, France, and the Netherlands. Notably, the Netherlands experienced the most dramatic growth in export value (+182.0%), becoming a major hub, while traditional leaders like Germany (+14.5%) and France (+44.7%) also posted strong gains.

Source: Top EU Exporters by Value

Key Export Destinations Remain Developed Economies

The United States and the United Kingdom are the EU's principal non-EU export markets. Exports to the US grew strongly (+52.6%), reflecting robust demand, while the UK market also expanded (+28.7%). Other significant destinations include Switzerland, Norway, and Australia, indicating that EU producers primarily serve mature, high-income healthcare markets.

II. A Dramatic Surge in Imports Reshapes the EU's Trade Balance

While maintaining a trade surplus, the EU's import dynamics have been characterized by rapid growth, fundamentally altering the sourcing landscape for medical furniture and introducing new competitive pressures.

Import Value and Volume More Than Double

EU imports of medical furniture saw explosive growth, with their value increasing by 106.6% to reach €440 million by 2025. The volume imported grew even faster, rising by 68.4% to 36,353 tonnes. This indicates that the EU is sourcing significantly more product from the rest of the world, though at a slower pace in value terms than in volume, pointing to generally lower average import prices compared to exports.

China Emerges as the Dominant Supplier, While New Entrants Grow Rapidly

China is the largest single source of imports, with its shipments to the EU surging by 163.1% over the period. The United States remains the second-largest supplier. However, the most striking growth has come from Türkiye (+455.3%) and, to a lesser extent, the United Kingdom (+44.4%) and Taiwan (+122.7%). This diversification highlights evolving global supply chains and competitive manufacturing capabilities.

Source: Top EU Import Partners by Value

Import Sourcing Becomes Slightly More Concentrated

Despite the entry of new suppliers, the Herfindahl-Hirschman Index (HHI) for import value indicates a modest increase in concentration (+3.1%). The HHI for import volume, however, rose sharply (+44.8%), suggesting that the growth in physical shipments has been dominated by a smaller group of major suppliers, most notably China.

III. Strategic Positioning: Resilience, Specialization, and Market Volatility

The EU's trade patterns reveal a sector with strong productive foundations but facing increasing import competition and specific volatility risks in its supply chains.

The EU Maintains Autonomy and Strengthens its Export-Oriented Position

The EU remains a net exporter of medical furniture. Its net import reliance improved over the period, moving from -20.7% in 2015 to -26.9% in 2025, meaning exports exceeded imports by a larger margin relative to the sector's size. Concurrently, the sector's export propensity increased significantly (+52.3%), indicating that EU production is increasingly geared towards foreign markets.

Specialization is Rooted in Central and Western Europe

Analysis of revealed comparative advantage shows that Poland and Czechia are the most specialized EU producers of this goods category. Germany and the Netherlands also demonstrate a high degree of specialization. This specialization, coupled with strong production growth (+137.4% in value), forms the backbone of the EU's competitive export capacity.

Volatility and Supply Shocks are Pervasive in Import Chains

The EU's import relationships exhibit significant volatility. The coefficient of variation for imports from Türkiye (0.56) and India (0.64) is notably high, indicating unstable trade flows. The analysis also detected a major price shock event in 2021 related to exports to the United Kingdom, with a 47.9% price shift. This volatility underscores the supply chain risks associated with sourcing, even as the EU strategically reduces its net import reliance.

Conclusion

Between 2015 and 2025, the EU's market for medical furniture (CN 940290) has evolved into a globally competitive sector characterized by robust export performance and a rapidly expanding import base. The EU has successfully leveraged its high-value production base, centered in Germany and Central Europe, to become a dominant global exporter, with shipments growing in both value and sophistication. Simultaneously, the near-doubling of imports, driven overwhelmingly by China, reflects intensified global competition and the integration of new, cost-competitive supply chains into the EU market. Despite this import surge, the EU has strengthened its overall strategic autonomy in the sector, improving its net trade surplus and increasing its export propensity. Looking ahead, the key dynamic will be the balance between sustaining the EU's high-end export competitiveness and managing the risks associated with a more volatile and concentrated import portfolio.